Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets
2016
This case study describes the challenges of scaling up the delivery of vaccines in low-income settings. The case focuses on the dengue vaccine, first launched in 2015, and explores issues of affordability, distribution, and the role of innovation across industries. It is accompanied by a complementary case, Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (B): Business Model Innovation in Vaccine Delivery.
This case study is offered for a small fee by Harvard Business School Publishing, which serves as a bridge between academia and enterprises around the world through its myriad publications—including cases, articles, simulations, books and chapters, online courses, and “core curriculum” modules on foundational topics—and content-delivery platforms. Any registered user can create personalized libraries with shareable folders of resources, and individuals with “Premium Educator access” may access publications for free as well as unlock supplemental materials, including teaching notes.
Source:
Parker P, Marion P. Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets. Harvard Business School Publishing 2016. https://cb.hbsp.harvard.edu/cbmp/product/IN1139-PDF-ENG.